US87583X1090
US87583X1090
Tango Therapeutics, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 62.384.000 | 42.069.000 | 48.3% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 173.673.000 | 187.664.000 | 7.5% | |
| Operating Income | -111.289.000 | -145.595.000 | 23.6% |
| Pretax Income | -101.590.000 | -130.094.000 | 21.9% |
| Net Income Common Stockholders | -101.594.000 | -130.302.000 | 22.0% |
| -- | -- | -- | |
| -- | -- | -- |